FMR »

Aprea Therapeutics shares owned by FMR

Quarter-by-quarter ownership of Aprea Therapeutics (APRE) shares owned by FMR from 13F filings

Historical chart of FMR investment in Aprea Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aprea Therapeutics held by FMR consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aprea Therapeutics by FMR

Quarter filed Position value Share count Share price at filing
2026-06-30 $36 45 0.80
2025-06-30 $852 501 1.70
2024-03-31 $1.1k 161 6.69

More positions owned by FMR

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Micron Technology (MU)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Ge Vernova (GEV)
Exxon Mobil Corporation (XOM)
Ge Aerospace Com New (GE)

View all positions for FMR

Top funds holding Aprea Therapeutics

AIGH Capital Management
Vestal Point Capital
Sphera Funds Management
Nantahala Capital Management
Renaissance Technologies
Geode Capital Management
Citadel Advisors
Bnp Paribas Arbitrage, Snc
Diadema Partners
Vanguard Fiduciary Trust
Susquehanna International
Vanguard Capital Management
Morgan Stanley
LPL Financial
HighTower Advisors

View all funds holding Aprea Therapeutics